Use of MicroRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells
US9023821B2 · kind B2 · utility
3Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2010 |
| Grant date | May 5, 2015 |
| Priority date | — |
| Expiry date | Jul 26, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/178
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for evaluating the regenerative and/or differentiation capacity of ciliated epithelial tissue in a vertebrate subject, in particular a mammal, preferably a human, and to the use of microRNA in treating illnesses associated with a dysfunction of multiciliated epithelial cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.